Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 6/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.42 |
| ▸ | PIM1 | P11309 | 3/20 | 0.42 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.39 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2023297 | 0.92 | CYP2A6 (0.58) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL2813022 | 0.87 | CYP2A6 (0.52) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL24345106 | 0.86 | CYP2A6 (0.54) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL28548915 | 0.86 | HPGDS (0.45) | CYP11B1CYP11B2 | |
| SCHEMBL29959399 | 0.86 | HPGDS (0.45) | CYP11B1CYP11B2 | |
| SCHEMBL9973765 | 0.83 | CYP2A6 (0.51) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL2022016 | 0.83 | CYP19A1 (0.49) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9973755 | 0.83 | CYP2A6 (0.51) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL22470317 | 0.83 | CYP2A6 (0.52) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL20010147 | 0.82 | CYP3A4 (0.47) | CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240099130-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2024-03-21 | — | — | US | disclosed |
| US-11856846-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-26 | — | — | US | disclosed |
| US-20210320261-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
| US-11081648-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD. (KR) | 2021-08-03 | — | — | US | disclosed |
| CN-107880025-B | Organic compound, and organic light emitting diode and organic light emitting display device including the same | 乐金显示有限公司 | 2021-06-15 | — | — | CN | disclosed |
| EP-3301093-B1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO LTD (KR) | 2020-04-29 | — | — | EP | disclosed |
| US-10468605-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD. (KR) | 2019-11-05 | — | — | US | disclosed |
| EP-3301093-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG Display Co., Ltd. (KR) | 2018-04-04 | — | — | EP | disclosed |
| US-20180090686-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180090686-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090686-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | CYP2A6 547/4885CYP3A4 65/4885CYP19A1 1250/4885 |
| US-20240099130-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | CYP2A6 547/4885CYP3A4 65/4885CYP19A1 1250/4885 |
| US-20210320261-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | CYP2A6 560/4885CYP3A4 67/4885CYP19A1 1268/4885 |
| US-11856846-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD1, OCIAD2, AOX1 | CYP2A6 560/4885CYP3A4 67/4885CYP19A1 1268/4885 |
| US-10468605-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD1, OCIAD2, AOX1 | CYP2A6 547/4885CYP3A4 65/4885CYP19A1 1250/4885 |
| US-11081648-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD1, OCIAD2, AOX1 | CYP2A6 547/4885CYP3A4 65/4885CYP19A1 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.